These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23486739)

  • 1. Liposomes and nanotechnology in drug development: focus on neurological targets.
    Ramos-Cabrer P; Campos F
    Int J Nanomedicine; 2013; 8():951-60. PubMed ID: 23486739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
    Bertalan F; László B; Attila V
    Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation.
    May JN; Golombek SK; Baues M; Dasgupta A; Drude N; Rix A; Rommel D; von Stillfried S; Appold L; Pola R; Pechar M; van Bloois L; Storm G; Kuehne AJC; Gremse F; Theek B; Kiessling F; Lammers T
    Theranostics; 2020; 10(4):1948-1959. PubMed ID: 32042346
    [No Abstract]   [Full Text] [Related]  

  • 6. Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal.
    Kanwar JR; Sun X; Punj V; Sriramoju B; Mohan RR; Zhou SF; Chauhan A; Kanwar RK
    Nanomedicine; 2012 May; 8(4):399-414. PubMed ID: 21889479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
    Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
    Tam VH; Sosa C; Liu R; Yao N; Priestley RD
    Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders.
    Hassanzadeh P; Atyabi F; Dinarvand R
    Life Sci; 2017 Aug; 182():93-103. PubMed ID: 28583367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in nanomaterials for neural applications: opportunities and challenges.
    Sisubalan N; Shalini R; Ramya S; Sivamaruthi BS; Chaiyasut C
    Nanomedicine (Lond); 2023 Nov; 18(26):1979-1994. PubMed ID: 38078433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
    Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
    Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
    Vlieghe P; Khrestchatisky M
    Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-enabled delivery systems across the blood-brain barrier.
    Hwang SR; Kim K
    Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug targeting strategies into the brain for treating neurological diseases.
    Barnabas W
    J Neurosci Methods; 2019 Jan; 311():133-146. PubMed ID: 30336221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier.
    Vieira DB; Gamarra LF
    Int J Nanomedicine; 2016; 11():5381-5414. PubMed ID: 27799765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based nanoformulations in the treatment of neurological disorders.
    Pottoo FH; Sharma S; Javed MN; Barkat MA; Harshita ; Alam MS; Naim MJ; Alam O; Ansari MA; Barreto GE; Ashraf GM
    Drug Metab Rev; 2020 Feb; 52(1):185-204. PubMed ID: 32116044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine in Neuroprotection, Neuroregeneration, and Blood-Brain Barrier Modulation: A Narrative Review.
    Krsek A; Jagodic A; Baticic L
    Medicina (Kaunas); 2024 Aug; 60(9):. PubMed ID: 39336425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colloidal supramolecular aggregates for therapeutic application in neuromedicine.
    Cosco D; Di Marzio L; Marianecci C; Trapasso E; Paolino D; Celia C; Carafa M; Fresta M
    Curr Med Chem; 2014; 21(36):4132-53. PubMed ID: 25174931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological disorders and therapeutics targeted to surmount the blood-brain barrier.
    Kanwar JR; Sriramoju B; Kanwar RK
    Int J Nanomedicine; 2012; 7():3259-78. PubMed ID: 22848160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes and nanotechnology in drug development: focus on ocular targets.
    Honda M; Asai T; Oku N; Araki Y; Tanaka M; Ebihara N
    Int J Nanomedicine; 2013; 8():495-503. PubMed ID: 23439842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.